MYL7: A Potential Drug Target for Cancer and Other Diseases (G58498)

Target Name: MYL7

NCBI ID: G58498

MYL7

MYL7: A Potential Drug Target for Cancer and Other Diseases

Myosin, light polypeptide 7 (MYL7), is a protein that plays a critical role in muscle physiology. It is a non-muscle protein that is expressed in a variety of tissues, including heart, lungs, and brain. MYL7 is involved in the regulation of muscle growth, contraction, and relaxation. It is also involved in the development and maintenance of muscle mass.

MYL7 has been identified as a potential drug target and biomarker for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders.

Disease andMYL7

One of the key functions of MYL7 is its role in muscle physiology.MYL7 helps regulate the contraction and relaxation of muscles. It does this by interacting with the myosin heads, which are the parts of the muscle protein that do the actual work.MYL7 helps keep the myosin heads in the correct position, so they can do their job efficiently.

MYL7 is also involved in the regulation of muscle mass. It helps to build and maintain muscle mass by promoting muscle cell growth and by preventing muscle cell death. This is important for maintaining muscle mass and strength, which is important for overall health and quality of life.

MYL7 and Cancer

MYL7 has also been identified as a potential drug target for cancer. Cancer is a leading cause of death in the world, and there is a need for new treatments to address this. MYL7 has been shown to be involved in the development and progression of cancer . It has been shown to contribute to the development of cancer by promoting the growth and survival of cancer cells.

MYL7 has also been shown to be involved in the regulation of cell division. It helps to control the number of cells that divide, which is important for maintaining tissue growth and development. MYL7 may also be involved in the development of some forms of cancer by disrupting the normal cell division that occurs in cancer cells.

MYL7 and Cardiovascular Disease

MYL7 is also involved in the regulation of cardiovascular disease. It helps to keep the heart and blood vessels healthy by promoting blood flow and by maintaining the proper functioning of the heart muscle. This is important for maintaining cardiovascular health and preventing the development of heart disease.

MYL7 has been shown to be involved in the regulation of blood pressure. It helps to keep blood pressure within a normal range by controlling the contraction and relaxation of blood vessels. This is important for maintaining cardiovascular health and preventing the development of heart disease.

MYL7 and Neurological Disorders

MYL7 is also involved in the regulation of neurological disorders. It helps to keep the brain and nervous system healthy by promoting blood flow and by maintaining the proper functioning of the brain cells. This is important for maintaining neurological health and preventing the development of neurological disorders..

MYL7 has been shown to be involved in the regulation of muscle tone. It helps to keep muscle tone in check, which is important for maintaining proper muscle function and preventing muscle weakness or spasticity.

MYL7 as a Drug Target

MYL7 has been identified as a potential drug target for a variety of diseases. Researchers are studying the effects of different drugs on MYL7 to see if they can be used to treat cancer, cardiovascular disease, and neurological disorders.

MYL7 may be an effective drug target for cancer because it has been shown to contribute to the development and progression of cancer. It may also be an effective drug target for other diseases because it is involved in the regulation of important physiological processes that are involved in the development and progression of many diseases.

Conclusion

MYL7 is a protein that plays a critical role in muscle physiology and the regulation of many important physiological processes in the body. It has

Protein Name: Myosin Light Chain 7

The "MYL7 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MYL7 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets